Synco Bio Partners
AMSTERDAM, May 11, 2011 - SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of
biopharmaceuticals, announced today that it has signed an agreement with
Syntaxin to produce its novel drug candidate SXN101959.
AMSTERDAM, May 3, 2010 - SynCo Bio Partners B.V., an award winning GMP biopharmaceutical
manufacturer, has expanded its current agreement with OncoMed
Pharmaceuticals, Inc., a company developing novel therapeutics that
target cancer stem cells.
